US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
US7132427B2
(en)
|
2001-06-21 |
2006-11-07 |
Ariad Pharmaceuticals, Inc. |
Quinazolines and uses thereof
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
US7524852B2
(en)
|
2002-06-07 |
2009-04-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Bicyclic pyrimidine derivatives
|
US7423044B2
(en)
|
2002-09-05 |
2008-09-09 |
Wyeth |
Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia
|
AR044743A1
(en)
*
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
HERBICIDE, METHOD OF USE, DERIVED FROM REPLACED TIENOPIRIMIDINE, INTERMEDIATE COMPOUNDS, AND PROCEDURES USED TO PRODUCE THEM,
|
US7196106B2
(en)
|
2002-11-05 |
2007-03-27 |
Merck & Co., Inc |
Cyanothiophene derivatives, compositions containing such compounds and methods of use
|
WO2004047755A2
(en)
|
2002-11-22 |
2004-06-10 |
Japan Tobacco Inc. |
Fused bicyclic nitrogen-containing heterocycles
|
WO2004052862A1
(en)
*
|
2002-12-10 |
2004-06-24 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
MXPA05011103A
(en)
|
2003-04-16 |
2005-12-12 |
Hoffmann La Roche |
Quinazoline compounds useful as p38 kinase inhibitors.
|
AU2004229163A1
(en)
|
2003-04-16 |
2004-10-28 |
F. Hoffmann-La Roche Ag |
(6-(phenoxy)-pyrido`3,4-d! PYRIMIDIN-2-YL)-AMINE DERIVATIVES AS P38 KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORYY CONDITIONS SUCH AS RHEUMATOIS ARTRITIS
|
JP2007501801A
(en)
|
2003-08-07 |
2007-02-01 |
日本たばこ産業株式会社 |
Pyrrolo [1,2-b] pyridazine derivatives
|
WO2005016925A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Pfizer Limited |
Azaquinazoline derivatives
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
EP1724264A1
(en)
*
|
2004-03-10 |
2006-11-22 |
Ono Pharmaceutical Co., Ltd. |
Nitriles and medicinal compositions containing the same as the active ingredient
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
US7598259B2
(en)
|
2004-06-15 |
2009-10-06 |
Schering Corporation |
mGluR1 antagonists as therapeutic agents
|
AR049300A1
(en)
|
2004-06-15 |
2006-07-12 |
Schering Corp |
MGLUR1 ANTAGONIST TRICICLIC COMPOUNDS AS THERAPEUTIC AGENTS
|
CA2573999A1
(en)
|
2004-07-16 |
2006-04-06 |
Sunesis Pharmaceuticals, Inc. |
Thienopyrimidines useful as aurora kinase inhibitors
|
US7928107B2
(en)
|
2004-09-02 |
2011-04-19 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US8283354B2
(en)
|
2004-09-02 |
2012-10-09 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
KR20070057914A
(en)
*
|
2004-09-02 |
2007-06-07 |
버텍스 파마슈티칼스 인코포레이티드 |
Quinazolines useful as modulators of ion channels
|
GB0420719D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
US7745451B2
(en)
|
2005-05-04 |
2010-06-29 |
Renovis, Inc. |
Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions
|
US7825244B2
(en)
|
2005-06-10 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
|
US8071768B2
(en)
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
CN101277939A
(en)
*
|
2005-09-09 |
2008-10-01 |
布里斯托尔-迈尔斯斯奎布公司 |
Acyclic ikur inhibitors
|
CA2633035C
(en)
|
2005-12-15 |
2016-05-10 |
Rigel Pharmaceuticals, Inc. |
Kinase inhibitors and their uses
|
HUP0501170A2
(en)
*
|
2005-12-20 |
2007-09-28 |
Richter Gedeon Nyrt |
2-heteroaryl-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical compositions containing them
|
EA200801536A1
(en)
*
|
2005-12-20 |
2008-12-30 |
Рихтер Гедеон Нирт. |
NEW TIENOPYRESULPHONE DERIVATIVES
|
HUP0501168A3
(en)
*
|
2005-12-20 |
2007-10-29 |
Richter Gedeon Nyrt |
2-(acyl, oxycarbonyl or aminocarbonyl)-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical composition containing them
|
EA200801535A1
(en)
*
|
2005-12-20 |
2008-12-30 |
Рихтер Гедеон Нирт. |
NEW THYENOPYRIDONE DERIVATIVES
|
RU2467007C2
(en)
|
2005-12-21 |
2012-11-20 |
Эбботт Лэборетриз |
[1,8]naphthyridine derivatives, useful as inhibitors of hcv virus replication
|
EP2345652A1
(en)
|
2005-12-21 |
2011-07-20 |
Abbott Laboratories |
Antiviral compounds
|
US7915411B2
(en)
|
2005-12-21 |
2011-03-29 |
Abbott Laboratories |
Anti-viral compounds
|
WO2007076034A2
(en)
|
2005-12-21 |
2007-07-05 |
Abbott Laboratories |
Anti-viral compounds
|
TWI417095B
(en)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
|
DE102006012251A1
(en)
*
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituted 4-aminoquinazoline derivatives and their use for the preparation of medicaments
|
EP1921070A1
(en)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
|
SI2083811T1
(en)
|
2006-11-22 |
2017-02-28 |
Clinical Research Associates, Llc |
Methods of treating down's syndrome, fragile x syndrome and autism
|
CA2672737A1
(en)
|
2006-12-20 |
2008-11-06 |
Abbott Laboratories |
Anti-viral compounds
|
KR20090116782A
(en)
|
2007-02-06 |
2009-11-11 |
베링거 인겔하임 인터내셔날 게엠베하 |
Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
US20090209536A1
(en)
*
|
2007-06-17 |
2009-08-20 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
AU2008282032B2
(en)
|
2007-08-02 |
2014-08-07 |
Recordati Ireland Limited |
Novel heterocyclic compounds as mGlu5 antagonists
|
ES2365966T3
(en)
|
2007-09-14 |
2011-10-14 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
4- (ARIL-X-FENIL) -1H-PIRIDIN-2-ONAS 1,3-DISUSTITUED.
|
PT2203439E
(en)
|
2007-09-14 |
2011-02-11 |
Ortho Mcneil Janssen Pharm |
1`,3`-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1`h-ý1, 4`¨bipyridinyl-2`-ones
|
KR20100111291A
(en)
|
2008-02-07 |
2010-10-14 |
베링거 인겔하임 인터내셔날 게엠베하 |
Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
|
WO2009138781A1
(en)
|
2008-05-13 |
2009-11-19 |
Astrazeneca Ab |
Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
|
JP5539351B2
(en)
|
2008-08-08 |
2014-07-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cyclohexyloxy-substituted heterocycles, medicaments containing these compounds, and methods for producing them
|
CA2735764C
(en)
|
2008-09-02 |
2016-06-14 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
US8759362B2
(en)
*
|
2008-10-24 |
2014-06-24 |
Purdue Pharma L.P. |
Bicycloheteroaryl compounds and their use as TRPV1 ligands
|
JP5539376B2
(en)
*
|
2008-11-19 |
2014-07-02 |
エボテック (ユーエス) インコーポレイテッド |
6,7-Dihydro-5H-pyrrolo [3,4-D] pyrimidin-4-yl] quinolin-3-ylamine compounds useful as FAAH modulators and uses thereof
|
MX2011005242A
(en)
|
2008-11-28 |
2011-09-06 |
Ortho Mcneil Janssen Pharm |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors.
|
WO2010077613A1
(en)
*
|
2008-12-09 |
2010-07-08 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
WO2010089119A1
(en)
|
2009-02-04 |
2010-08-12 |
Recordati Ireland Limited |
Heterocyclic derivatives as m-glu5 antagonists
|
MX2011011964A
(en)
|
2009-05-12 |
2012-02-23 |
Janssen Pharmaceuticals Inc |
1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders.
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
AR076859A1
(en)
|
2009-05-12 |
2011-07-13 |
Ortho Mcneil Janssen Pharm |
DERIVATIVES OF 1,2,4-TRIAZOLO [4,3-A] PIRIDINE POSITIVE MODULATORS OF MGLUR2 RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USE OF THE SAME IN THE TREATMENT OF NEUROLOGICAL AND SYNCHIATRIC DISORDERS.
|
WO2011029633A1
(en)
|
2009-09-14 |
2011-03-17 |
Recordati Ireland Limited |
Heterocyclic mglu5 antagonists
|
WO2011106276A1
(en)
*
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Task channel antagonists
|
WO2011109398A2
(en)
|
2010-03-02 |
2011-09-09 |
President And Fellows Of Harvard College |
Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
|
US20110294879A1
(en)
|
2010-05-28 |
2011-12-01 |
Xenoport, Inc. |
Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
|
BR112013000529B1
(en)
*
|
2010-07-09 |
2019-11-19 |
Recordati Ireland Ltd |
spiroheterocyclic compounds as mglu5 antagonists and pharmaceutical composition containing said compounds
|
WO2012009646A1
(en)
|
2010-07-15 |
2012-01-19 |
Xenoport, Inc. |
Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
|
JP2013539762A
(en)
|
2010-10-08 |
2013-10-28 |
アッヴィ・インコーポレイテッド |
Furo [3,2-d] pyrimidine compounds
|
WO2012054724A1
(en)
|
2010-10-21 |
2012-04-26 |
Massachusetts Institute Of Technology |
Methods of treating seizure disorders
|
CN103298809B
(en)
|
2010-11-08 |
2016-08-31 |
杨森制药公司 |
1,2,4-triazol [4,3-a] pyridine derivate and the purposes of the positive allosteric modulators as MGLUR2 acceptor thereof
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
PL2649069T3
(en)
|
2010-11-08 |
2016-01-29 |
Janssen Pharmaceuticals Inc |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
US10799504B2
(en)
|
2012-01-13 |
2020-10-13 |
ACEA Therapeutics, Inc. |
Heterocyclic compounds and uses as anticancer agents
|
US9586965B2
(en)
|
2012-01-13 |
2017-03-07 |
Acea Biosciences Inc. |
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
|
US9464089B2
(en)
|
2012-01-13 |
2016-10-11 |
Acea Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
US9034885B2
(en)
|
2012-01-13 |
2015-05-19 |
Acea Biosciences Inc. |
EGFR modulators and uses thereof
|
TWI499591B
(en)
|
2013-01-11 |
2015-09-11 |
Lilly Co Eli |
Bicyclic pyrimidine compounds
|
TW201520219A
(en)
*
|
2013-03-12 |
2015-06-01 |
Lilly Co Eli |
Imidazo pyridine compounds
|
TW201500356A
(en)
*
|
2013-04-12 |
2015-01-01 |
Lilly Co Eli |
Dihydropyrido pyrimidine compounds
|
JO3368B1
(en)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
CN112592334B
(en)
|
2013-07-11 |
2023-10-27 |
艾森医药公司 |
Pyrimidine derivatives as kinase inhibitors
|
JO3367B1
(en)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
AU2015208233B2
(en)
|
2014-01-21 |
2019-08-29 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
PT3096790T
(en)
|
2014-01-21 |
2019-10-15 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
WO2015162518A1
(en)
|
2014-04-25 |
2015-10-29 |
Pfizer Inc. |
Heteroaromatic compounds and their use as dopamine d1 ligands
|
CN108290855A
(en)
*
|
2015-07-01 |
2018-07-17 |
西北大学 |
Substituted quinazoline compound and its purposes for adjusting glucocerebrosidase activity
|
DK3325490T3
(en)
|
2015-07-23 |
2020-02-03 |
Takeda Pharmaceuticals Co |
1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDINE-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS
|
JP6889494B2
(en)
|
2015-10-09 |
2021-06-18 |
エイシア セラピューティクス, インコーポレイテッド |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making them.
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
JP2020516682A
(en)
|
2017-04-07 |
2020-06-11 |
エイシア セラピューティクス, インコーポレイテッド |
Pharmaceutical salts, physical forms and compositions of pyrrolopyrimidine kinase, and methods of making the same
|
US11919833B2
(en)
*
|
2021-04-26 |
2024-03-05 |
Mitsubishi Gas Chemical Company, Inc. |
Compound and method for producing same
|